Welcome to our dedicated page for Monroe Capital news (Ticker: MRCC), a resource for investors and traders seeking the latest updates and insights on Monroe Capital stock.
Monroe Capital Corporation (MRCC) is a leading specialty finance company providing customized debt solutions to lower middle-market businesses in the U.S. and Canada. This page serves as the definitive source for MRCC news, offering investors and analysts timely updates on strategic developments.
Access press releases covering earnings reports, portfolio company acquisitions, and partnership announcements. Stay informed about regulatory filings and dividend declarations while tracking MRCC's performance in private credit markets. Our curated news collection helps stakeholders monitor risk management practices and investment strategy evolution.
Discover updates on senior secured lending activities, unitranche facility deployments, and equity co-investments. Content is organized to highlight financial results, leadership insights, and market positioning within the business development company (BDC) sector. Bookmark this page for efficient tracking of MRCC's role in bridging financing gaps for growing enterprises.
Monroe Capital (MRCC) reported its Q3 2024 financial results with Net Investment Income (NII) of $6.5 million, or $0.30 per share. The company maintained its quarterly dividend of $0.25 per share, offering a 12.3% annual yield. Net Asset Value (NAV) slightly decreased to $198.9 million ($9.18 per share) from $199.3 million ($9.20 per share) in Q2 2024. The portfolio consists primarily of first lien loans (80.0%) with investments in 94 portfolio companies totaling $474.3 million. The weighted average contractual and effective yields decreased to 11.0% from 11.9% in Q2, primarily due to declining base rates and an additional portfolio company placed on non-accrual status.
Monroe Capital (NASDAQ: MRCC) has announced the schedule for its third quarter 2024 earnings release and conference call. The company will report its financial results for the quarter ended September 30, 2024, on Tuesday, November 12, 2024, after the financial markets close. Following this, MRCC will host a webcast and conference call on Wednesday, November 13, 2024, at 11:00 a.m. Eastern Time to discuss the operating and financial results.
Investors can access the webcast through a link in the Investor Relations section of the company's website. To join the conference call, participants should dial (800) 715-9871 about 10 minutes before the call, using conference ID # 5769748. For those unable to attend the live event, a replay of the webcast will be available on the company's website approximately two hours after the event concludes.
Monroe Capital (NASDAQ: MRCC) has declared a distribution of $0.25 per share for the third quarter of 2024. The distribution is payable on September 30, 2024 to stockholders of record as of September 16, 2024. The company has a dividend reinvestment plan in place, which automatically reinvests distributions in additional shares of the company's capital stock for stockholders who have not opted out prior to the record date. The specific tax characteristics of the distribution will be reported to stockholders on Form 1099 after the end of the calendar year and in the company's periodic report filed with the SEC.
Monroe Capital (NASDAQ: MRCC) disclosed its financial results for Q2 2024 on August 7, 2024. Key highlights include:
Financial Performance: Net Investment Income (NII) of $6.6 million ($0.30 per share) and Adjusted NII of $6.7 million ($0.31 per share). Net increase in net assets resulting from operations was $3.3 million ($0.15 per share). Net Asset Value (NAV) decreased to $199.3 million ($9.20 per share).
Dividend: A $0.25 per share dividend was paid, maintaining a 14.0% annualized dividend yield.
Portfolio Overview: The portfolio includes 94 investments valued at $485.8 million, primarily first lien loans (81.1%). The weighted average yield was 11.9%, and loans on non-accrual status represented 1.9% of total investments.
CEO Theodore L. Koenig highlighted the company’s focus on portfolio quality and risk-adjusted returns amidst a high-interest rate environment.
Monroe Capital (NASDAQ: MRCC) has announced the schedule for its second quarter 2024 earnings release and conference call. The company will report its financial results on Wednesday, August 7, 2024, after the financial markets close. A webcast and conference call to discuss these results will be held on Thursday, August 8, 2024, at 11:00 a.m. Eastern Time.
Investors can access the webcast through the Investor Relations section of Monroe Capital's website. To join the conference call, participants should dial (800) 715-9871 about 10 minutes before the start time, using the conference ID # 7213559. For those unable to attend the live event, a replay of the webcast will be available on the company's website approximately two hours after the call concludes.
Monroe Capital (NASDAQ: MRCC) has declared a quarterly distribution of $0.25 per share for Q2 2024. The dividend is payable on June 28, 2024, to shareholders on record by June 17, 2024. The company's dividend reinvestment plan, adopted in October 2012, allows distributions to be reinvested in additional shares unless shareholders opt for cash. The tax characteristics of the distribution will be detailed in Form 1099 and included in the company's periodic SEC filing.
Monroe Capital (MRCC) announced its financial results for the first quarter of 2024, with Net Investment Income of $5.5 million and Adjusted Net Investment Income of $5.5 million, resulting in a net increase in net assets of $3.2 million. The Net Asset Value (NAV) was $201.5 million. Monroe's CEO highlighted the 16th consecutive quarter of covering dividends with Adjusted Net Investment Income. Despite a decrease in Adjusted Net Investment Income from the previous quarter, the company remains focused on credit quality and enhancing risk-adjusted returns by leveraging market dynamics.
FAQ
What is the current stock price of Monroe Capital (MRCC)?
What is the market cap of Monroe Capital (MRCC)?
